Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007
Medication labelWhy this: Advisory · dailymed-prescription
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5% is an alpha-adrenergic receptor agonist with a beta-adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP; the IOP-lowering of brimonidine tartrate/timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day.
- generic_name
- brimonidine tartrate and timolol maleate
- product_names
- Brimonidine Tartrate and Timolol Maleate
- ndc
- 65145-162, 65145-163, 65145-164, 65145-162-01, 65145-163-01, 65145-164-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en